Resverlogix Corp.

Investor Documents

Information regarding the notice of Special Meeting of Shareholders of Resverlogix Corp. to be held on May 28, 2013 and Management Information Circular with respect to Plan of Arrangement involving Resverlogix Corp., RVX Therapeutics Inc., 1741273 Alberta Ltd. and the Shareholders of Resverlogix Corp. please access PDF document below titled Management Information Circular April 29, 2013.

The following documents require Adobe Acrobat Reader click to download.

Management Information Circular April 29, 2013

January 31, 2013 Financial Statement

January 31, 2013 MD&A

October 31, 2012 Financial Statement

October 31, 2012 MD&A

2012 Annual Report

Experts Corner Sept. 2012: Seven Innovative Biotechs

Experts Corner May 2012: Not All HDL Are Created Equal

Experts Corner Feb. 2012: RVX-208 & Neurodegenerative Diseases

Experts Corner Nov. 2011: RVX-208 vs. CETP Inhibitors

Pursuit of Atheroma Regression: Resverlogix White Paper

Information Circular 2012

July 31, 2012 Financial Statement

July 31, 2012 MD&A

Year End April 30, 2012 Financial Statement

Year End April 30, 2012 MD&A

January 31, 2012 Financial Statement

January 31, 2012 MD&A

2011 Annual Report

October 31, 2011 Financial Statement

October 31, 2011 MD&A

July 31, 2011 Financial Statements

July 31, 2011 MD&A

Year End April 30, 2011 Financial Statement

Year End April 30, 2011 MD&A

January 31, 2011 MD&A

January 31, 2011 Financial Statements